News

The preclinical study showed that intranasal administration of OMV-Spike protected against the SARS-CoV-2 virus.

Oral vancomycin prophylaxis was found by a small study to prevent C diff infection in thoracic transplant patients.

Current evidence remains uncertain to predict natural immunity conferred by SARS-CoV-2 infection, according to living practice points developed by the American College of Physicians (ACP), which urges patients to continue infection prevention practices such as hand washing, mask wearing and maintaining physical distance.

While it was a small study, its findings indicate protection against COVID-19 variants from the vaccine and from recovery from the infection.

The therapy used plasma from recoverees with high levels of antibodies and proved to significantly improve clinical outcomes.

mRNA-1273 was seen to elicit antibodies for COVID-19 180 days following full dosage in a phase 1 trial and is still recommended for use by the authors.

The study suggests that proper air ventilation and masks could reduce the risk of infections in classrooms by up to 50%, making a 6-foot social distancing requirement unnecessary.

Laboratory escape is described as an extremely unlikely source for SARS-CoV-2 in new WHO report, but questions posed to the researchers remain open.

As we hopefully inch closer to a point where COVID-19 numbers are declining and vaccinations are increasing, there is more attention to what risk factors might impact infections, hospitalizations, and mortality.

The crossover will allow all trial participants to receive the vaccine while remaining blinded.

2020 forced clinicians and people with HIV (PWH) to adapt to the COVID-19 pandemic. While initially it had an immediate impact on patient care, new solutions and strategies were created to ensure health care was delivered to those who needed it.

Biopharmaceutical company, NeuroRx, reported positive data from its phase 2/3 trial for its therapy, aviptadil acetate (Zyesami), in patients with severe COVID-19.

India recorded over 100,000 cases on Sunday, the countries highest daily total ever.

An expert stresses the need to consider individuals' worry over information—and even their history with systemic biases.

Vaccine access and new cases are both increasing. An expert discusses earning trust in at-risk communities.

The screening methods used in the study proved to be reliable and inexpensive alternatives to the current standard used in testing.

The study determined that acid-base disturbances like can influence the risk of a C diff infection after cardiac surgery is performed

Clostridium difficile infection (CDI) is a leading cause of healthcare-associated infections and the clinical spectrum ranges from asymptomatic colonization to toxic megacolon and fulminant colitis.

Health regulators in the UK have now found 30 cases involving rare blood clot events after the administration of the AstraZeneca COVID-19 vaccine, but still recommend its use.

Hospitalized patients with COVID-19 and chronic inflammatory diseases were seen to have no statistically significant increased length of hospital stay or need for mechanical ventilation.

The federal agency said people who are fully vaccinated “are less likely to get and spread COVID-19,” and can travel safely in the United States.

The 2 revisions made to the EUA pertain to the number of doses allotted to the current vials containing the vaccine, and allow a new vial that has a maximum of 15 doses.

Simplifying access to hepatitis C virus care, including decentralized community-based care and task shifting to non-specialists, could improve testing and treatment for patients in settings with limited resources.

Infection control efforts to combat hospital-onset Clostridioides difficile infection may be better spent on health care workers’ hand hygiene compliance and environmental cleaning than on visitor contact precautions, a new study suggests.

Investigators discovered that the variant was in many other countries before it was discovered and created a tool to help detect emerging variants in the future.

With the small size and portability of NIRVANA, the test could be used for fast virus detection at various locations and could be used to monitor wastewater or streams for the presence of new viruses.

The companies are now seeking a Biologics License Application with the FDA, which would allow it to become more greatly available for adults in the US.

Two randomized trials involved more than 4500 patients to determine the efficacy of a broadly neutralizing antibody in blocking acquisition of HIV infection.

A manufacturing plant that was set to produce the Janssen (Johnson & Johnson) vaccine mixed up the ingredients of 2 vaccines.

To date, there have been only a few small reports of seizures in patients with severe COVID-19 and the effects them on patients' health was previously unknown.